"A synergystic anti-cancer nootropic formula would be:" (list of stuff)
How do you know ? The last line on the linked web page says,
"The researchers want to do experiments to find out if this is the case. On lab animals."
Which means it's unproven in humans.
Elsewhere on the internet it say mice die quicker when flouracacil is combined with spirulina
"In conclusion, the present study describes the lack of antitumor activity of spirulina in EAC tumor-bearing mice model. In addition, spirulina administered simultaneously with fluorouracil did not enhance the antitumor activity of the later but rather resulted in increased dose-dependent mortality. In light of the present results, the mechanism of spirulina-induced mortality is not well understood. Although spirulina has been shown to possess anticancer effects in other models, the present study shows that it might not be a suitable therapeutic alternative for conventional chemotherapeutic agents in all settings such as EAC tumor-bearing mice model. In addition, spirulina might be not very safe, particularly when administered with other drugs such as fluorouracil. Therefore, we recommend that spirulina, or even other natural products, should be used cautiously and that possible interactions with other coadministered drugs should be monitored carefully."
Which again I guess is unproven in humans, but if we're basing our cures on mice only, then I'd have thought it might be a problem.
Well, anyway, I'm not any kind of biologist/physician so I'm backing out of this.***
Interesting web site, though (ergo), I'll be looking at that, thanks.
***except to add this
https://news.yale.edu/2018/07/19/complementary-medicine-cancer-can-decrease-survival
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result...
....“The fact that complementary medicine use is associated with higher refusal of proven cancer treatments as well as increased risk of death should give providers and patients pause,” said lead author
Skyler Johnson, M.D., chief resident in radiation oncology at Yale School of Medicine. “Unfortunately, there is a great deal of confusion about the role of complementary therapies. Although they may be used to support patients experiencing symptoms from cancer treatment, it looks as though they are either being marketed or understood to be effective cancer treatments.”